Indigo Biosciences, founded in 2005 and led by CEO Fred Marroni, develops products and services focused on nuclear receptors. The company offers screening services and assay kits for pharmaceutical, biotechnology, agri-business and nutriceutical firms, as well as government research agencies and academic researchers. Its CryoMite™ technology provides long-term cryo-preservation of cells for shipping and storage and underpins its product offerings. Indigo raised $500K in a Series B financing (part of an overall $1.5M target) to support growth. The company plans to use the funds for new product development, continued development of a European strategy, and expansion of domestic sales capabilities.

Total raised

$1M

Funding rounds

1

Latest round

Series B

Latest activity

Aug 2016